Second-generation antipsychotics and tardive syndromes in affective illness: a public health problem with neuropsychiatric consequences. [electronic resource]
- American journal of public health Feb 2015
- e10-6 p. digital
Publication Type: Journal Article
1541-0048
10.2105/AJPH.2014.302439 doi
Antipsychotic Agents--adverse effects Central Nervous System--drug effects Drug Labeling Humans Mood Disorders--drug therapy Movement Disorders--etiology United States United States Food and Drug Administration